GlaxoSmithKline (United States)
In research, GlaxoSmithKline (United States) stands highest in Medicine (#2,975 of 10,443 worldwide), Life Sciences (#2,223 of 7,800 worldwide) and Health Sciences (#4,090 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology and Microbiology and Epidemiology — Immunology and Microbiology is 7.1× its share of world research.
- World rank, 2022–2025
- #4,744 of 28,054 · #1,846 all time
- Rank in United States
- #659 of 4,192
- Research works
- 4.4k ▼ 4% vs 2013–17
- Citations
- 198k 45.3 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 39% world 28%
What is GlaxoSmithKline (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,975 of 10,443 | 14.9% | 290 | #1035 | |
| Life SciencesDomain | #2,223 of 7,800 | 21.8% | 117 | #713 | |
| Health SciencesDomain | #4,090 of 11,982 | 14.8% | 299 | #1272 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,578 of 3,579 | 20.0% | 68 | #901 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,035 #2,975
- Life Sciences#713 #2,223
- Health Sciences#1,272 #4,090
- Biochemistry, Genetics and Molecular Biology#901 #2,578
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does GlaxoSmithKline (United States) specialise in?
Where its research is concentrated relative to its size: Immunology and Microbiology takes 7.1× the share of its output that it takes of world research.
- Immunology and MicrobiologyField · 34.6 works7.1×
- EpidemiologySubfield · 47.5 works7.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.1×. Every wedge is a field page.
- Immunology and Microbiology 7.1×
- Pharmacology, Toxicology and Pharmaceutics 3.6×
- Veterinary 3.4×
- Medicine 3.1×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Chemistry 1.6×
- Economics, Econometrics and Finance 1.2×
- Mathematics 1.1×
- Decision Sciences 0.7×
- Neuroscience 0.6×
- Health Professions 0.5×
- Chemical Engineering 0.2×
- Nursing 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Energy 0.1×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at GlaxoSmithKline (United States)?
Ranked on the composite score, Vincent Mooser, Rafael Alfonso‐Cristancho and John Bertin lead among researchers whose main affiliation is GlaxoSmithKline (United States).
- 1 Vincent Mooser United States · #7,849 worldwide 1.5k citations · 53 works
- 2 Rafael Alfonso‐Cristancho United States · #30,580 worldwide 821 citations · 34 works
- 3 John Bertin United States · #46,913 worldwide 455 citations · 30 works
- 4 Axel Hoos United States · #51,441 worldwide 285 citations · 37 works
- 5 Catherine Ellis United States · #64,630 worldwide 316 citations · 28 works
- 6 Philip A. Harris United States · #66,879 worldwide 215 citations · 40 works
- 7 Ruth Tal‐Singer United States · #69,449 worldwide 211 citations · 54 works
- 8 Peter J. Gough United States · #160,020 worldwide 308 citations · 19 works
- 9 Deborah A. Smith United States · #161,066 worldwide 156 citations · 36 works
- 10 Tona M. Gilmer United States · #164,989 worldwide 197 citations · 27 works
Which keywords describe research at GlaxoSmithKline (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Inflammation, Immune Response, Treatment, Vaccine, Diagnosis, Pathogenesis and Immunology.
- Nanomedicine
- Herpesviruses
- Myelofibrosis
- Drug Resistance
- Prevention Strategies
- Microbiome
- Monoclonal Antibodies
- spirometry
- Vaccine Development
- Respiratory
- Treatment Guidelines
- Antimicrobial Resistance
- Allergic Diseases
- Clinical Trials
- Immunology
- Chemotherapy
- Pathogenesis
- Diagnosis
- Immune Response
- Inflammation
- Epidemiology
- Treatment
- Vaccine
- Management
- Genetics
- Quality of Life
- Asthma
- Global Burden
- Eosinophils
- Antiretroviral Therapy
- Biomarkers
- Immunity
- COPD
- Autoantibodies
- Glycosylation
- Catheter-Associated Infections
- Urinary Tract Infections
- JAK2 Mutation
- Herpes Zoster
- Therapeutic Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology90▲ 4.7×67 topics
- Inflammation40▲ 3.9×45 topics
- Treatment32▲ 5.5×28 topics
- Immune Response28▲ 10×15 topics
- Vaccine27▲ 14×11 topics
- Diagnosis24▲ 5.4×21 topics
- Management20▲ 5.3×11 topics
- Pathogenesis20▲ 8.1×16 topics
- Genetics20▲ 5.8×8 topics
- Chemotherapy19▲ 5.7×16 topics
- Quality of Life19▲ 2.7×18 topics
- Immunology18▲ 34×2 topics
- Asthma17▲ 37×2 topics
- Clinical Trials17▲ 5.3×12 topics
- Global Burden17▲ 6.6×10 topics
- Allergic Diseases16▲ 58×1 topic
- Eosinophils16▲ 58×1 topic
- Antimicrobial Resistance16▲ 17×6 topics
- Antiretroviral Therapy16▲ 20×5 topics
- Treatment Guidelines15▲ 15×4 topics
- Biomarkers15▲ 4.6×14 topics
- Respiratory14▲ 31×2 topics
- Immunity14▲ 7.0×9 topics
- Vaccine Development12▲ 10×8 topics
- COPD12▲ 37×1 topic
- spirometry12▲ 37×1 topic
- Autoantibodies12▲ 10×6 topics
- Monoclonal Antibodies12▲ 27×3 topics
- Glycosylation10▲ 19×3 topics
- Microbiome10▲ 16×2 topics
- Catheter-Associated Infections10▲ 64×1 topic
- Prevention Strategies10▲ 21×2 topics
- Urinary Tract Infections10▲ 51×1 topic
- Drug Resistance9▲ 6.6×6 topics
- JAK2 Mutation9▲ 78×1 topic
- Myelofibrosis9▲ 78×1 topic
- Herpes Zoster9▲ 61×1 topic
- Herpesviruses9▲ 61×1 topic
- Therapeutic Antibodies8▲ 25×2 topics
- Nanomedicine8▲ 22×2 topics
Which research topics does GlaxoSmithKline (United States) publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Urinary Tract Infections Management and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 16 works
- 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 12 works
- 3 Urinary Tract Infections Management Epidemiology 10 works
- 4 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 9 works
- 5 Herpesvirus Infections and Treatments Epidemiology 9 works
- 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 8 works
- 7 Respiratory viral infections research Epidemiology 8 works
- 8 Multiple Myeloma Research and Treatments Hematology 7 works
- 9 Ovarian cancer diagnosis and treatment Reproductive Medicine 7 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (United States)'s research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Philadelphia
- University of Pennsylvania
- Temple University
- Drexel University
- Thomas Jefferson University
- Children's Hospital of Philadelphia
- Philadelphia University
- Hospital of the University of Pennsylvania
- Fox Chase Cancer Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.